Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gadoquatrane Dose Finding for CNS MRI
NCT04307186Phase 2Completed
- Sponsor
- Bayer
- Start
- Nov 2020
- Primary completion
- Sep 2022
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of gadoquatrane in Central nervous system lesion, sponsored by Bayer. Started Nov 2020; status: completed.
02
Drugs
gadoquatrane
03
Conditions
Central nervous system lesion
Beyond the preview
Go deeper on NCT04307186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04307186.